September 19, 2008 - Boston Scientific Corp. announced this week a decision by the U.S. District Court in Delaware involving a case patent owned by Johnson & Johnson and Boston Scientific's NIR stent product.
In the decision, the Judge granted Johnson & Johnson's motion for entry of final judgment and denied Boston Scientific's motion for a new trial.
In 2000, a jury awarded Johnson & Johnson $324 million in damages based on Boston Scientific's sale of the NIR stent. The Court also awarded pre-judgment interest at prime rate based on after-tax damages.
The Order indicated that the Court will enter final judgment on Sept. 30, 2008.
Boston Scientific no longer sells the NIR stent, and announced that it will appeal this decision.
For more information: www.bostonscientific.com
June 12, 2024 
